PepGen's chart data is dated 2026-10-09. There is no active technical signal. There are 2 published signal records.
PepGen last closed at $2.62 (+10.08%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is -2.3×. Its overall grade ranks 306 of 738 stocks in Healthcare.
About this company
PepGen last closed at $2.62 (+10.08%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B · 306/738
Valuation grade B+
Related stocks
- BiogenCustomer
PepGen의 주요 공동개발·제휴 가능 고객/파트너로 거론되는 대형 바이오 기업
- Ionis PharmaceuticalsCompetitor
희귀질환·RNA 기반 치료제 분야에서 경쟁하는 대표적 바이오테크
- Sarepta TherapeuticsCompetitor
근이영양증 등 유전질환 치료제 시장에서 PepGen과 겹치는 경쟁사
About PepGen
- What technical signals does PepGen (PEPG) have?
- PepGen current technical signals: no active technical signal.
- Is PepGen a cup-and-handle pattern?
- No. PepGen has no valid Cup signal right now.
- What published figures are available for PepGen?
- Market cap: $180.12M. Trailing 12 months PER: -2.3×. Latest quarter PBR: 1.38×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about PepGen, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.